Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

NCT06130384 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT06130384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
Lead sponsor
Wills Eye
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2021
Completion date
November 15, 2023
Enrollment
97 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

intravitreal injection, pain, pain, acute